Peter R Gibson
Inflammatory bowel disease (IBD) is a common disease in
Australia and frequently encountered in primary care. Major
developments in investigation and management have taken place.
This article aims to review some recent breakthroughs in IBD
investigation and management.
Diagnosis involves a changing combination of enhanced
traditional techniques with new diagnostic tools, typically blood
and stool testing with improved endoscopy and new radiological
tests. Management has seen the introduction of new powerful
biologic therapies, greater understanding in the way we use
older therapies, and a focus on preventing complications such
as malignancy or infection. Treatment philosophy now attempts
to alter the natural history of the disease and prevent long
term complications. The importance of associated, previously
overlooked factors is being increasingly recognised. Only by
taking a long term, patient centred multidisciplinary approach
will an optimal outlook for the majority of patients with IBD be
Inflammatory bowel disease (IBD) refers to a group of conditions characterised by inflammation in the intestinal tract. Crohn disease (CD) and ulcerative colitis (UC) account for the majority of these conditions. The aim of this article is to review recent breakthroughs in IBD investigation and management. Several other comprehensive reviews and position statements are also available.1–4
Download the PDF for the full article.